Form 13-F position report

HIMS & HERS HEALTH INC COM

Reported by NewView Capital Partners I LLC

HIMS CUSIP 433000106 Manager CIK 0001750432

Reported 5,053,698 shares, unchanged from the prior quarter.

Reported value 23.2%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 11.71% This manager · Q3 2022
Shares 5,053,698 Quarter-end amount reported
Reported value $28,200,000 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 33102000
2022-03-31 26936000
2022-06-30 22893000
2022-09-30 28200000
2022-12-31 32394204
2023-03-31 50060615
2023-06-30 36993174
2023-09-30 24753943
2023-12-31 35025452
2024-03-31 60881319
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for HIMS & HERS HEALTH INC COM held by NewView Capital Partners I LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -3,935,444 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 3,935,444 0 (0.0%) 52.9% $60,881,319 2024-05-15
Q4 2023 Unchanged 3,935,444 0 (0.0%) 31.38% $35,025,452 2024-02-14
Q3 2023 Unchanged 3,935,444 0 (0.0%) 30.26% $24,753,943 2023-11-14
Q2 2023 Reduced 3,935,444 -1,110,989 (-22.0%) 32.47% $36,993,174 2023-08-14
Q1 2023 Reduced 5,046,433 -7,265 (-0.1%) 38.59% $50,060,615 2023-05-15
Q4 2022 Unchanged 5,053,698 0 (0.0%) 17.26% $32,394,204 2023-02-14
Q3 2022 Unchanged 5,053,698 0 (0.0%) 11.71% $28,200,000 2022-11-14
Q2 2022 Unchanged 5,053,698 0 (0.0%) 5.79% $22,893,000 2022-08-15
Q1 2022 Unchanged 5,053,698 0 (0.0%) 32.9% $26,936,000 2022-05-16
Q4 2021 New 5,053,698 +5,053,698 (0.0%) 27.27% $33,102,000 2022-02-14

Who else reported the position

161 managers reported HIMS & HERS HEALTH INC COM for Q3 2022.

Managers reporting HIMS & HERS HEALTH INC COM in Q3 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 11,115,192 -109,706 < 0.01% $62,022,000 7 qtrs
Redpoint Management LLC Unchanged 10,396,124 0 19.51% $58,010,000 4 qtrs
Forerunner Ventures Management LLC Unchanged 9,756,893 0 99.37% $54,443,000 4 qtrs
BlackRock Inc Reduced 8,351,770 -120,105 < 0.01% $46,604,000 7 qtrs
NewView Capital Partners I LLC This report Unchanged 5,053,698 0 11.71% $28,200,000 4 qtrs
Foresite Capital Management V LLC Unchanged 3,319,786 0 14.24% $18,524,000 7 qtrs
OAKTREE CAPITAL MANAGEMENT LP Unchanged 3,271,279 0 0.2% $18,253,000 7 qtrs
STATE STREET CORPORATION Added 3,021,045 +423,361 < 0.01% $16,857,000 7 qtrs
MARSHALL WACE LLP Added 2,250,429 +104,736 0.03% $12,559,000 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,116,345 +30,143 < 0.01% $11,809,000 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 14, 2022
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
5,053,698
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.